Xing-Juan Yu

1.7k total citations
29 papers, 1.3k citations indexed

About

Xing-Juan Yu is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Xing-Juan Yu has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in Xing-Juan Yu's work include Immune cells in cancer (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immune Cell Function and Interaction (6 papers). Xing-Juan Yu is often cited by papers focused on Immune cells in cancer (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Immune Cell Function and Interaction (6 papers). Xing-Juan Yu collaborates with scholars based in China, United States and Sweden. Xing-Juan Yu's co-authors include Limin Zheng, Jing Xu, Hong-Wei Sun, Wenchao Wu, Haitian Chen, Yongchun Wang, Yaojun Zhang, Zilian Wang, Chong Wu and Ya-Ming Meng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Xing-Juan Yu

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing-Juan Yu China 20 706 559 442 301 151 29 1.3k
Rindert Missiaen United States 8 336 0.5× 449 0.8× 432 1.0× 265 0.9× 155 1.0× 9 962
Lucy Ireland United Kingdom 10 408 0.6× 516 0.9× 353 0.8× 206 0.7× 138 0.9× 15 993
Elisa Rivas Spain 7 573 0.8× 1.0k 1.8× 455 1.0× 255 0.8× 182 1.2× 7 1.4k
Arnaud Jabouille France 8 378 0.5× 489 0.9× 454 1.0× 183 0.6× 143 0.9× 8 1.1k
Ece Kadioglu Switzerland 7 355 0.5× 462 0.8× 430 1.0× 255 0.8× 128 0.8× 8 883
Hallvard Haugen Norway 6 414 0.6× 517 0.9× 515 1.2× 181 0.6× 91 0.6× 10 1.1k
Alisha Holtzhausen United States 14 727 1.0× 628 1.1× 625 1.4× 201 0.7× 111 0.7× 22 1.3k
Kelly N. Fitzgerald United States 7 542 0.8× 650 1.2× 433 1.0× 174 0.6× 184 1.2× 16 1.1k
Manglio Rizzo Argentina 16 214 0.3× 388 0.7× 351 0.8× 155 0.5× 103 0.7× 44 910

Countries citing papers authored by Xing-Juan Yu

Since Specialization
Citations

This map shows the geographic impact of Xing-Juan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing-Juan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing-Juan Yu more than expected).

Fields of papers citing papers by Xing-Juan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing-Juan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing-Juan Yu. The network helps show where Xing-Juan Yu may publish in the future.

Co-authorship network of co-authors of Xing-Juan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xing-Juan Yu. A scholar is included among the top collaborators of Xing-Juan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing-Juan Yu. Xing-Juan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Rui, Jie Mei, Hao Zou, et al.. (2025). Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy. Cell Reports Medicine. 6(9). 102298–102298. 1 indexed citations
2.
Wang, Yongchun, Zhixiong Li, Junfeng Wang, et al.. (2024). C/EBPα mediates the maturation and antitumor functions of macrophages in human hepatocellular carcinoma. Cancer Letters. 585. 216638–216638. 4 indexed citations
3.
Wang, Yongchun, Rui Xing, Xing-Juan Yu, et al.. (2023). Cholesterol Efflux Drives the Generation of Immunosuppressive Macrophages to Promote the Progression of Human Hepatocellular Carcinoma. Cancer Immunology Research. 11(10). 1400–1413. 19 indexed citations
4.
Chen, Jing, Hong-Wei Sun, Yanyan Yang, et al.. (2021). Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer. Signal Transduction and Targeted Therapy. 6(1). 4–4. 82 indexed citations
5.
Huang, Zhijie, et al.. (2021). HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma. Biologics. Volume 15. 329–341. 14 indexed citations
6.
Sun, Hong-Wei, Wenchao Wu, Haitian Chen, et al.. (2021). Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF. Frontiers in Immunology. 11. 616367–616367. 33 indexed citations
7.
Sun, Hong-Wei, Jing Chen, Wenchao Wu, et al.. (2020). Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer. Cancer Immunology Research. 9(1). 20–33. 20 indexed citations
8.
Wang, Junfeng, Yongchun Wang, Zhixiong Li, et al.. (2020). Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma. Journal of Hepatology. 74(3). 627–637. 104 indexed citations
9.
Wu, Wenchao, Hong-Wei Sun, Jing Chen, et al.. (2019). Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer. Cancer Immunology Research. 7(10). 1605–1618. 49 indexed citations
10.
Liao, Jing, Jinqing Li, Yongchun Wang, et al.. (2019). CD103+ tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma. Journal of Cancer. 10(21). 5234–5243. 21 indexed citations
11.
Xiao, Gang, Chaoqun Liu, Yongchun Wang, et al.. (2019). EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 300–300. 135 indexed citations
12.
Liu, Chaoqun, Jing Xu, Zhongguo Zhou, et al.. (2018). Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma. British Journal of Cancer. 119(1). 80–88. 82 indexed citations
13.
Xu, Jing, Jing Liang, Ya-Ming Meng, et al.. (2017). Vascular CXCR4 Expression Promotes Vessel Sprouting and Sensitivity to Sorafenib Treatment in Hepatocellular Carcinoma. Clinical Cancer Research. 23(15). 4482–4492. 42 indexed citations
14.
Li, Jinqing, Xing-Juan Yu, Yongchun Wang, et al.. (2017). Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer. Journal of Translational Medicine. 15(1). 37–37. 38 indexed citations
15.
Zhou, Yun, Yongwen Huang, Xinping Cao, et al.. (2016). WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition. PLoS ONE. 11(8). e0160414–e0160414. 27 indexed citations
16.
Sun, Hong-Wei, Xing-Juan Yu, Wenchao Wu, et al.. (2016). GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma. PLoS ONE. 11(12). e0168907–e0168907. 91 indexed citations
17.
Wu, Wenchao, Hong-Wei Sun, Haitian Chen, et al.. (2014). Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proceedings of the National Academy of Sciences. 111(11). 4221–4226. 160 indexed citations
18.
Wang, Bo, Lian Li, Yuan Liao, et al.. (2013). Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma. Cancer Immunology Immunotherapy. 62(10). 1575–1585. 63 indexed citations
19.
Peng, Ruiqing, Chunyan Li, Xing-Juan Yu, et al.. (2011). Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer. Jiefangjun yixue zazhi. 36(3). 281–286. 1 indexed citations
20.
Wang, Bo, Dazhi Xu, Xing-Juan Yu, et al.. (2011). Association of Intra-tumoral Infiltrating Macrophages and Regulatory T Cells Is an Independent Prognostic Factor in Gastric Cancer after Radical Resection. Annals of Surgical Oncology. 18(9). 2585–2593. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rindert Missiaen Breakdown of academic impact, for papers by Lucy Ireland Breakdown of academic impact, for papers by Elisa Rivas Breakdown of academic impact, for papers by Arnaud Jabouille Breakdown of academic impact, for papers by Ece Kadioglu Breakdown of academic impact, for papers by Hallvard Haugen Breakdown of academic impact, for papers by Alisha Holtzhausen Breakdown of academic impact, for papers by Kelly N. Fitzgerald Breakdown of academic impact, for papers by Manglio Rizzo
Rankless by CCL
2026